Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Net Income towards Common Stockholders: 2013-2024

Historic Net Income towards Common Stockholders for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $12.5 million.

  • Surgery Partners' Net Income towards Common Stockholders rose 29531.25% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year decrease of 7797.73%. This contributed to the annual value of $12.5 million for FY2024, which is 20504.2% up from last year.
  • Per Surgery Partners' latest filing, its Net Income towards Common Stockholders stood at $12.5 million for FY2024, which was up 20504.2% from -$11.9 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Net Income towards Common Stockholders registered a high of $12.5 million during FY2024, and its lowest value of -$155.6 million during FY2020.
  • For the 5-year period, Surgery Partners' Net Income towards Common Stockholders averaged around -$58.2 million, with its median value being -$54.6 million (2022).
  • Per our database at Business Quant, Surgery Partners' Net Income towards Common Stockholders crashed by 4081.45% in 2020 and then surged by 20504.2% in 2024.
  • Surgery Partners' Net Income towards Common Stockholders (Annual) stood at -$155.6 million in 2020, then surged by 47.81% to -$81.2 million in 2021, then skyrocketed by 32.76% to -$54.6 million in 2022, then soared by 78.21% to -$11.9 million in 2023, then soared by 205.04% to $12.5 million in 2024.
  • Its Net Income towards Common Stockholders stands at $12.5 million for FY2024, versus -$11.9 million for FY2023 and -$54.6 million for FY2022.